| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2013-12-10 15:58:04 |
| Periods | |
| Versijas komentārs | |
| Teksts |
Olainfarm will Hold Third Quarter 2013 Investor Conference WebinarAS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its second quarter 2013 investor conference webinar scheduled on December 10, 2013 at 16:00 (EET). Webinar will be hosted by the member of the management board Salvis Lapiņš. The presentation will be in English. During the webinar topics in relation to AS “Olainfarm” latest activities and analysis of third quarter 2013 financial results will be discussed. After the presentation investors will be welcomed to ask questions. Due to the limited webinar time, please send in your questions in advance till December 9 to e-mail: ieva.kadakovska@nasdaqomx.com.
What is
webinar?
How to
join the webinar? Additional
information on the webinar The enclosed presentation will be presented during the webinar.
A/s OlainFarm is one of the biggest pharmaceutical companies in Latvia with 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information
prepared by: |
| Pielikumi |